Welcome to our dedicated page for CALAVO GROWERS SEC filings (Ticker: CVGW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CALAVO GROWERS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CALAVO GROWERS's regulatory disclosures and financial reporting.
Mission Produce and Calavo announced that Mexico's Federal Economic Competition Commission (COFECE) granted antitrust clearance. The companies stated that this satisfies the Mexican closing condition in their merger agreement and, subject to continued satisfaction of all closing conditions, they currently expect the Mergers to close on May 28, 2026. The filing notes the Registration Statement on Form S-4 (File No. 333-294128) and that the definitive Joint Proxy Statement/Prospectus was mailed on or about March 25, 2026.
AllianceBernstein L.P. reported beneficial ownership of 1,267,054 shares of Calavo Growers Inc Common Stock, representing 7.1% of the class as disclosed in a Schedule 13G. The filing shows sole dispositive power for 1,267,054 shares and sole voting power for 747,938 shares.
Calavo Growers, Inc. Schedule 13G: Rubric Capital Management and David Rosen report beneficial ownership of 1,416,662 shares, representing 7.93% of Calavo's 17,874,079 outstanding shares as of March 16, 2026.
The filing states the shares are held by Rubric Funds (including Rubric Capital Master Fund LP) with shared voting and dispositive power reported. The statement notes standard disclosures about beneficial ownership attribution and includes a joint filing agreement.
Calavo Growers, Inc. reported that at a special shareholder meeting on April 28, 2026 shareholders approved the Agreement and Plan of Merger with Mission Produce, Inc., as described in the companies' joint proxy statement/prospectus. A total of 13,082,457 shares were present or represented by proxy (approximately 73.19% of outstanding).
The record date for the meeting was March 16, 2026, when 17,874,079 shares of common stock were outstanding. The non-binding advisory proposal on merger-related executive compensation did not receive the requisite shareholder support. Closing of the Mergers is expected during the fiscal quarter ending July 31, 2026, subject to regulatory approvals in Mexico and other customary closing conditions; Calavo common stock is expected to be halted and delisted upon closing.
Calavo Growers, Inc. shareholders approved the Agreement and Plan of Merger with Mission Produce, Inc. at a special meeting held on April 28, 2026. The merger will occur through a two-step structure in which Calavo is first merged into a Mission subsidiary and then into a second Mission entity.
Of 17,874,079 shares entitled to vote, 13,082,457 shares were present, and the merger agreement received 12,110,759 votes in favor. A separate, non-binding advisory proposal on merger-related executive compensation did not pass. Closing still depends on regulatory approvals in Mexico, and Calavo’s Nasdaq listing is expected to end once the mergers close.
CALAVO GROWERS INC Chief Executive Officer Bruce John Lindeman reported equity compensation-related transactions involving company stock. On April 23, 2026, he exercised derivative awards classified as restricted stock units to acquire 4,259 shares of common stock at an exercise price of $0.0000 per share.
On the same date, 1,587 shares of common stock were disposed of in a tax-withholding transaction at $27.86 per share to cover obligations tied to the award. After these transactions, Lindeman directly held 24,556 shares of CALAVO GROWERS INC common stock. Footnotes also describe separate restricted stock units representing a contingent right to receive 2,220 shares of common stock, which fully vested earlier with receipt deferred under the award agreement.
CALAVO GROWERS INC director J. Link Leavens exercised equity awards and updated his holdings. On April 23, 2026, he exercised 4,259 Restricted Stock Units, receiving the same number of common shares at a stated price of $0.00 per share.
After this exercise, Leavens directly owns 89,858 shares of common stock. He also indirectly owns 266,413 shares held in the names of various partnerships where he shares voting and investment power, as described in the footnotes. Each restricted stock unit represents a contingent right to receive one Calavo common share, with vesting tied to a one-year anniversary of grant or the company’s 2026 annual meeting of shareholders.
Calavo Growers director Kathleen M. Holmgren reported the vesting and exercise of restricted stock units into common stock. She acquired 4,259 shares of Calavo Growers common stock at a price of $0.00 per share through a derivative exercise, bringing her direct ownership to 26,950 shares. The corresponding 4,259 restricted stock units, each representing a contingent right to receive one share, were reduced to zero, reflecting a routine equity compensation event rather than an open-market trade.
Calavo Growers director Michael Anthony DiGregorio exercised 4,259 restricted stock units into common stock. Each unit represented a right to receive one Calavo share, and this exercise increased his direct common stock holdings to 39,450 shares following the transaction.
Director Marc Laurence Brown of Calavo Growers Inc exercised restricted stock units into common shares. He converted 4,259 restricted stock units into 4,259 shares of common stock, with no cash exercise price reported. Following this transaction, he directly holds 32,700 shares of Calavo common stock. The filing shows no remaining derivative position from these restricted stock units, indicating they have been fully converted into shares.